Inspection Record

Pro-Tam — Health Canada Inspection Findings

Health CanadaInspected 2022-05-25 5 findingsOther quality systemComplaint and recall handlingDeviation, CAPA, and investigationRegulatory reporting and change controlStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Other quality system

The implementation of a self-inspection program was inadequate.

2Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

3Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

4Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

5Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-05-25. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Pro-Tam company profile — full history Health Canada documents, 2022 Go to Findings search